UCFA
BMY.RT

United Capital Financial Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

United Capital Financial Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-108,707
Closed -$75K – 1256
2020
Q4 		$75K Sell
108,707
-257
-0.2% -$547 ﹤0.01% 1160
2020
Q3 		$245K Sell
108,964
-622
-0.6% -$1.78K ﹤0.01% 1020
2020
Q2 		$392K Sell
109,586
-16,706
-13% -$60.3K ﹤0.01% 942
2020
Q1 		$480K Buy
126,292
+7,078
+6% +$23.3K ﹤0.01% 834
2019
Q4 		$359K Buy
+119,214
New +$310K ﹤0.01% 1080

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

United Capital Financial Advisors's BMY.RT Position: Q1 2021 in Review

United Capital Financial Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 108,707 shares — an estimated $75K sold.

United Capital Financial Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $480K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • United Capital Financial Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • United Capital Financial Advisors sold 108,707 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $75K.
  • United Capital Financial Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • United Capital Financial Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $480K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on United Capital Financial Advisors's 13F filing for Q1 2021, filed 14 May 2021.